Brain Implant Can Read Movement Of Parkinson's Patients, Opening Door To More Effective Treatment
via HealthDayTUESDAY, Feb. 17, 2026 — A new advance might help doctors improve movement in people with Parkinson’s disease by tracking their gait-related brain waves in real time.
An experimental brain implant can capture the signals of movement-related brain regions while Parkinson’s patients perform daily activities like walking to the kitchen or strolling through a park, researchers reported Feb. 13 in the journal Science Advances.
What’s more, researchers have figured out how to read those brain recordings, allowing a deeper understanding of the gait problems associated with Parkinson’s, researchers said.
Based on those readings, the implants could potentially be programmed to send electrical stimulation that matches what a Parkinson’s patient is doing, potentially improving their movement.
“This is the first demonstration that a fully implanted device can be used to detect a specific movement state in humans during real-world activity,” said senior researcher Dr. Doris Wang, an associate professor of neurological surgery at the University of California-San Francisco.
“Our findings show that it is possible to identify meaningful neural signals outside the laboratory, which is an important step toward more personalized and responsive neuromodulation therapies,” Wang said in a news release.
Movement problems are a major symptom of Parkinson’s — short and shuffling steps, stiffness, instability, tremors and involuntary actions, researchers said.
For the study, researchers recruited four Parkinson’s disease patients who were slated to receive deep brain stimulation implants. These implants can reduce Parkinson’s symptoms by sending electrical pulses to brain regions that control movement.
The four patients received implants that not only emit electrical pulses but also can record brain activity, researchers said.
The research team then tracked the patients through more than 80 hours of unsupervised daily activity. During this time, the patients also wore a sensor on their ankle that captured their walking gait, so researchers could compare that data to the brain waves occurring during movement.
Results showed that walking could be distinguished from non-walking states based on brain waves alone, using patterns that varied between individuals.
Based on this feedback from a person’s implant, doctors might be able to tweak the deep brain stimulation they receive to fit whether they are walking, sitting or performing some other activity, researchers said.
“We identified personalized neural biomarkers associated with gait and demonstrated that these signals can be used for real-time movement state classification within the constraints of an implanted device,” Wang said. “This establishes a framework for future adaptive DBS systems that could adjust stimulation in response to a patient’s activity state.”
For example, the implants might be set up to provide stimulation that’s optimized for walking, whenever they sense that a Parkinson’s patient is up and about.
However, more research is needed to fully explore how brain waves might be used to allow implants to adapt to a person’s current movement, researchers said.
“By enabling the study of brain activity during natural behavior, the approach may ultimately expand the reach of brain-computer interfaces and adaptive neuromodulation beyond controlled laboratory environments and into everyday life,” Wang said.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-18 13:38
Read more
- Harmony Biosciences Receives U.S. Food and Drug Administration Approval for Wakix (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
- Disc Medicine Receives Complete Response Letter from FDA for Bitopertin for the Treatment of EPP
- Couples Who Do This One Thing Feel More Satisfied And Secure Together
- Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010
- Risk Factors Associated With Child Food Allergy Identified
- Overweight, Obesity Remained Highly Prevalent in U.S. Youths in 2024
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions